Dana Poff

    Dana Poff photo
    Ms. Dana Poff
    Executive Vice President, Program Management

    Ms. Dana Poff is Executive Vice President, Program Management and is a member of ICON’s Leadership Team. In her role, Dana has global responsibility for the delivery of ICON’s clinical research programs across all therapeutic areas. Dana has over 27 years of clinical research experience, almost all of which have been with ICON. She joined ICON as Project Manager in 1997 and over time held roles of increasing responsibility, including Global Head of Project Management and Clinical Operations, President of Alliance Management and Chief of Staff. Dana left ICON in 2017 to become Chief Operating Officer of a life science technology company, before re-joining ICON in January 2019 to take up her current role. Prior to ICON, Dana was at ClinTrials Research and she also has experience in neonatal and paediatric nursing, having worked at Vanderbilt University Hospital.

    Kim Boericke

      Kim Boericke photo
      Ms. Kim Boericke
      President of ICON Commercialisation & Outcomes Services
      Ms. Kim Boericke is President of ICON Commercialisation & Outcomes Services, having previously served as EVP Global Program Management, where she was responsible for a number of therapeutic units (Oncology, Cardiovascular/Metabolic Diseases, CNS and Aging Diseases, Rare Diseases, Infectious Disease and Vaccines, Internal Medicine and Immunosciences, and Biosimilars). Prior to joining ICON, Ms. Boericke has held positions with several clinical research organisations (CROs), including ClinTrials, Quintiles, INC Research, Duke Clinical Research Institute, and i3. Ms. Boericke graduated with a Batchelor of Science degree from Duke University in 1989.


      Search Investor